"Natural history" of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease
- PMID: 11463591
- DOI: 10.1164/ajrccm.164.2.2006129
"Natural history" of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease
Abstract
The prognostic value and the evolution of pulmonary hypertension (PH) in patients with markedly hypoxemic chronic obstructive pulmonary disease (COPD), treated or not with long-term oxygen therapy (LTOT), has been extensively investigated. However, little is known in patients with mildly or moderately hypoxemic COPD not requiring LTOT. Therefore, we assessed the evolution of pulmonary hemodynamics in 131 patients with stable COPD by performing two right heart catheterizations at a mean (+/- SD) time interval of 6.8 +/- 2.9 yr. At inclusion (T0), no patient had PH (i.e., the mean pulmonary artery pressure [Ppa] at rest was < 20 mm Hg). Group 1 included 55 patients without exercising PH and group 2 included 76 patients with exercising PH, defined by a pulmonary arterial pressure (Ppa) > 30 mm Hg during a steady-state 40-W exercise. Group 2 patients compared with group 1 patients had a significantly higher resting Ppa (16 +/- 3 mm Hg versus 14 +/- 2 mm Hg, p = 0.001). At the second catheterization, 33 (25%) patients (9 of 55 in group 1, 24 of 76 in group 2, p = 0.048) showed a resting Ppa > 20 mm Hg, but PH was generally mild, ranging from 20 to 42.5 mm Hg. The mean Ppa at second evaluation was 16 +/- 5 mm Hg in group 1 and 19 +/- 7 mm Hg in group 2 (p = 0.01). The patients who developed resting PH at the second catheterization (T1) had higher resting and exercising Ppa (p = 0.001 and p = 0.002, respectively), and significantly lower resting and exercising Pa(O(2)) (p = 0.005 and p = 0.012, respectively) at T0. Logistic regression analysis showed that resting and exercising Ppa were independent predictors (at T0) for the subsequent development of PH (p = 0.029 and p = 0.027, respectively). The patients who developed resting PH (T1) had a significantly worsening of Pa(O(2)) (from 63.5 mm Hg at T0 to 60 mm Hg at T1, p = 0.047), whereas the Pa(O(2)) as a mean was stable in the remainder (69.5 mm Hg at T0 and T1). These results show the following. The progression of Ppa over time in patients with COPD with mild to moderate hypoxemia is rather slow, the average change for the group as a whole being of + 0.4 mm Hg/yr. Only about 25% of patients with COPD with mild to moderate hypoxemia and without resting PH at the onset will develop PH during a 6-yr follow-up. The patients with exercising PH at the onset have a significantly increased risk of developing PH over time. Only resting and exercising Ppa at the onset are independently related to the subsequent development of PH. However, in individual cases, the models of linear or logistic regression do not allow a pertinent prediction of the level of Ppa or the presence of PH at the second right heart catheterization.
Similar articles
-
Effect of lung volume reduction surgery on gas exchange and pulmonary hemodynamics at rest and during exercise.Am J Respir Crit Care Med. 1998 Oct;158(4):1020-5. doi: 10.1164/ajrccm.158.4.9710057. Am J Respir Crit Care Med. 1998. PMID: 9769254
-
Haemodynamic responses to exercise in patients with COPD.Eur Respir J. 2013 May;41(5):1031-41. doi: 10.1183/09031936.00085612. Epub 2012 Aug 16. Eur Respir J. 2013. PMID: 22903957
-
Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease.Am Rev Respir Dis. 1985 Apr;131(4):493-8. doi: 10.1164/arrd.1985.131.4.493. Am Rev Respir Dis. 1985. PMID: 3922267
-
Pulmonary hypertension in chronic obstructive pulmonary disease.Pneumonol Alergol Pol. 2013;81(4):390-8. Pneumonol Alergol Pol. 2013. PMID: 23744170 Review.
-
Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases.Semin Respir Crit Care Med. 2009 Aug;30(4):458-70. doi: 10.1055/s-0029-1233315. Epub 2009 Jul 24. Semin Respir Crit Care Med. 2009. PMID: 19634085 Review.
Cited by
-
Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension.J Appl Physiol (1985). 2015 Nov 15;119(10):1164-72. doi: 10.1152/japplphysiol.00283.2015. Epub 2015 Apr 30. J Appl Physiol (1985). 2015. PMID: 25930027 Free PMC article. Review.
-
Pulmonary Hypertension Secondary to COPD.Pulm Med. 2012;2012:203952. doi: 10.1155/2012/203952. Epub 2012 Aug 29. Pulm Med. 2012. PMID: 22973510 Free PMC article.
-
Targeted treatment in COPD: a multi-system approach for a multi-system disease.Int J Chron Obstruct Pulmon Dis. 2009;4:321-35. doi: 10.2147/copd.s2999. Epub 2009 Sep 1. Int J Chron Obstruct Pulmon Dis. 2009. PMID: 19750192 Free PMC article. Review.
-
Pathophysiology and clinical implications of pulmonary arterial enlargement in COPD.Int J Chron Obstruct Pulmon Dis. 2013;8:509-21. doi: 10.2147/COPD.S52204. Epub 2013 Oct 29. Int J Chron Obstruct Pulmon Dis. 2013. PMID: 24235822 Free PMC article. Review.
-
Pulmonary hypertension and chronic cor pulmonale in COPD.Int J Chron Obstruct Pulmon Dis. 2007;2(3):273-82. Int J Chron Obstruct Pulmon Dis. 2007. PMID: 18229565 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources